PALISADE CAPITAL MANAGEMENT, LP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$1,138,000
+29.3%
1,331,0000.0%0.04%
+24.2%
Q2 2017$880,000
-21.8%
1,331,0000.0%0.03%
-23.3%
Q1 2017$1,125,000
-11.4%
1,331,0000.0%0.04%
-10.4%
Q4 2016$1,270,000
-23.9%
1,331,000
-0.4%
0.05%
-18.6%
Q3 2016$1,668,000
+3.8%
1,336,000
-5.3%
0.06%
+1.7%
Q2 2016$1,607,000
-26.0%
1,411,0000.0%0.06%
-18.3%
Q1 2016$2,172,000
+9.5%
1,411,000
+5.5%
0.07%
+10.9%
Q4 2015$1,984,000
-10.1%
1,337,000
-5.2%
0.06%
-1.5%
Q3 2015$2,206,000
-13.2%
1,410,000
+16.5%
0.06%0.0%
Q2 2015$2,542,000
-1.2%
1,210,000
-5.7%
0.06%0.0%
Q1 2015$2,572,000
+5.7%
1,283,0000.0%0.06%
+10.2%
Q4 2014$2,434,000
+22.0%
1,283,0000.0%0.06%
+15.7%
Q3 2014$1,995,000
+15.2%
1,283,0000.0%0.05%
+21.4%
Q2 2014$1,732,000
+32.6%
1,283,000
+0.3%
0.04%
+31.2%
Q1 2014$1,306,000
-7.3%
1,279,000
-5.5%
0.03%
-13.5%
Q4 2013$1,409,000
-56.1%
1,353,000
-61.7%
0.04%
-57.5%
Q3 2013$3,209,0003,529,0000.09%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 16,490,000$25,947,00012.49%
SILVERBACK ASSET MANAGEMENT LLC 14,500,000$22,711,0002.37%
TANG CAPITAL MANAGEMENT LLC 3,500,000$5,259,0001.94%
ARISTEIA CAPITAL, L.L.C. 11,932,000$18,727,0000.95%
WOLVERINE ASSET MANAGEMENT LLC 12,600,000$19,576,0000.46%
Polar Capital LLP 3,120,000$4,965,0000.10%
Tekla Capital Management LLC 1,485,000$2,336,0000.08%
MIZUHO SECURITIES USA LLC 194,000$305,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 1,410,000$2,206,0000.06%
LAZARD ASSET MANAGEMENT LLC 11,010,000$17,375,0000.04%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders